• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Poland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018 - Product Image

Poland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

  • Published: September 2012
  • Region: Poland
  • 69 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • Animas Corporation
  • Eli Lilly and Company
  • LifeScan, Inc.
  • Nipro Corpora
  • Sanofi
  • MORE

Poland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

Summary

Global Markets Direct’s new report, “Poland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on the Poland Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD READ MORE >

1
1 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In Poland 8
3.1 Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 8
3.2 Diabetes Care Devices, Poland, Company Share (2010-2011) 13
4 Glucose Monitoring In Poland 15
4.1 Glucose Monitoring Overall Revenue, (2004-2018) 15
4.1.1 Blood Glucose Meters, Revenue (2004-2018) 19
4.2 Glucose Monitoring Overall Volume (2004-2018) 23
4.2.1 Blood Glucose Meters, Volume (2004-2018) 27
4.3 Glucose Monitoring Average Price (2004-2018) 29
4.4 Glucose Monitoring Distribution Share (2010-2011) 30
4.5 Glucose Monitoring, Poland, Company Share (2010-2011) 31
5 Insulin Delivery In Poland 33
5.1 Insulin Delivery Overall Revenue, (2004-2018) 33
5.1.1 Insulin Pens, Revenue (2004-2018) 37
5.1.2 Insulin Pumps, Revenue (2004-2018) 41
5.2 Insulin Delivery Overall Volume (2004-2018) 43
5.2.1 Insulin Pens, Volume (2004-2018) 47
5.2.2 Insulin Pumps, Volume (2004-2018) 51
5.3 Insulin Delivery Average Price (2004-2018) 53
5.4 Insulin Delivery Distribution Share (2010-2011) 54
5.5 Insulin Delivery, Poland, Company Share (2010-2011) 55
6 Overview of Key Companies in Poland Diabetes Care Devices Market 57
6.1 F. Hoffmann-La Roche Ltd. 57
6.1.1 Company Overview 57
6.2 LifeScan, Inc. 57
6.2.1 Company Overview 57
6.3 Bayer HealthCare AG 58
6.3.1 Company Overview 58
6.4 Sanofi 58
6.4.1 Company Overview 58
6.5 Abbott Laboratories 59
6.5.1 Company Overview 59
6.6 Becton, Dickinson and Company 59
6.6.1 Company Overview 59
6.7 Eli Lilly and Company 60
6.7.1 Company Overview 60
6.8 Medtronic, Inc. 60
6.8.1 Company Overview 60
6.9 Novo Nordisk A/S 61
6.9.1 Company Overview 61
6.10 Terumo Corporation 61
6.10.1 Company Overview 61
6.11 Animas Corporation 62
6.11.1 Company Overview 62
6.12 Abbott Laboratories 62
6.12.1 Company Overview 62
6.13 Nipro Corporation 62
6.13.1 Company Overview 62
7 Appendix 63
7.1 Global Markets Direct Research Methodology 63
7.2 Definitions of Markets Covered in the Report 64
7.2.1 Diabetes Care Devices 64
7.3 Secondary Research 67
7.4 Primary Research 67
7.5 Models 68
7.6 Forecasts 68
7.7 Expert Panel Validation 68
7.8 Currency Conversion 69
7.9 Contact Us 69
7.10 Disclaimer 69

1.1 List of Tables
Table 1: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 8
Table 2: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Historic, 2004-2011 10
Table 3: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 12
Table 4: Diabetes Care Devices, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 14
Table 5: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 16
Table 6: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 18
Table 7: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 20
Table 8: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 22
Table 9: Glucose Monitoring, Poland, Volume (Units) by Segment, Historic, 2004-2011 24
Table 10: Glucose Monitoring, Poland, Volume (Units) by Segment, Forecast, 2011-2018 26
Table 11: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 27
Table 12: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 28
Table 13: Glucose Monitoring, Poland, Average Price ($), Historic, 2004-2011 29
Table 14: Glucose Monitoring, Poland, Average Price ($), Forecast, 2011-2018 29
Table 15: Glucose Monitoring, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 30
Table 16: Glucose Monitoring, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 32
Table 17: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 34
Table 18: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 36
Table 19: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 38
Table 20: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 40
Table 21: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant, Historic, 2004-2011 41
Table 22: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant, Forecast, 2011-2018 42
Table 23: Insulin Delivery, Poland, Volume (Units) by Segment, Historic, 2004-2011 44
Table 24: Insulin Delivery, Poland, Volume (Units) by Segment, Forecast, 2011-2018 46
Table 25: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 48
Table 26: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 50
Table 27: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Historic, 2004-2011 51
Table 28: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Forecast, 2011-2018 52
Table 29: Insulin Delivery, Poland, Average Price ($), Historic, 2004-2011 53
Table 30: Insulin Delivery, Poland, Average Price ($), Forecast, 2011-2018 53
Table 31: Insulin Delivery, Poland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 54
Table 32: Insulin Delivery, Poland, Company Share by Revenue ($m), USD Constant, 2010-2011 56

1.2 List of Figures
Figure 1: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, 2004-2018 8
Figure 2: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Historic, 2004-2011 9
Figure 3: Diabetes Care Devices, Poland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 11
Figure 4: Diabetes Care Devices, Poland, Company Share (%), 2011 13
Figure 5: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 15
Figure 6: Glucose Monitoring, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 17
Figure 7: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 19
Figure 8: Blood Glucose Meters, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 21
Figure 9: Glucose Monitoring, Poland, Volume (Units) by Segment, Historic, 2004-2011 23
Figure 10: Glucose Monitoring, Poland, Volume (Units) by Segment, Forecast, 2011-2018 25
Figure 11: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 27
Figure 12: Blood Glucose Meters, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 28
Figure 13: Glucose Monitoring, Poland, Company Share (%), 2011 31
Figure 14: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 33
Figure 15: Insulin Delivery, Poland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 35
Figure 16: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 37
Figure 17: Insulin Pens, Poland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 39
Figure 18: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant, Historic, 2004-2011 41
Figure 19: Insulin Pumps (Traditional Insulin Pumps), Poland, Revenue ($m) USD Constant, Forecast, 2011-2018 42
Figure 20: Insulin Delivery, Poland, Volume (Units) by Segment, Historic, 2004-2011 43
Figure 21: Insulin Delivery, Poland, Volume (Units) by Segment, Forecast, 2011-2018 45
Figure 22: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Historic, 2004-2011 47
Figure 23: Insulin Pens, Poland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 49
Figure 24: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Historic, 2004-2011 51
Figure 25: Insulin Pumps (Traditional Insulin Pumps), Poland, Volume (Units), Forecast, 2011-2018 52
Figure 26: Insulin Delivery, Poland, Company Share (%), 2011 55
Figure 27: Our Methodology 63

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Bayer HealthCare AG
Sanofi
Abbott Laboratories
Becton, Dickinson and Company
Eli Lilly and Company
Medtronic, Inc.
Novo Nordisk A/S
Terumo Corporation
Animas Corporation
Abbott Laboratories
Nipro Corpora

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos